How can NETRI help you save Time and Resources
in your Preclinical Studies?
Reduce the 85% failure rate in clinical phases with NETRI’s cutting-edge organs-on-chip technology. Our high-throughput data and AI-driven predictive analytics accelerate drug discovery, providing reliable data to enhance research outcomes while seamlessly integrating into your workflows and reducing both costs and time.

What is NETRI?
NETRI has developed a unique value proposition in the organ-on-chip market : human cell-based assays to catalog and learn the complex language of human neurons and translate for pharmaceutical, nutrition & dermo-cosmetics industries developing treatment across all applications.
Accompanying their clients throughout the development life of their product, by providing predictive datas or platforms to understand modes of action in discovery, preclinical or clinical phases.
The use of human neural circuits coupled to multiple cell types opens the way to more personalized medicine as well as faster and more relevant diagnostics.
12
Patents
50+
People
70+
Clients
SERVICES
NETRI Services combines expert teams, unique know-how, and advanced technologies to facilitate the adoption of neuro-organs-on-chip for any application. We offer translation of partners’ reliable cell lines into our microfluidic devices, interpreting them into relevant readouts.
Designed to accelerate the time-to-market of treatments and products, NETRI Services seamlessly integrates with partners' existing research processes, providing dedicated expert support.
IN YOUR LAB
Full support services to set up your team with full in-house capabilities in organs-on-chip. NETRI's Field Application Scientists are on hand from start to finish to help you get the most out of our devices.
- Virtual & On-site Training
- User Experience
- Adapted Protocols & Videos
- Dedicated spaces

User Experience
in service

Adapted Protocols

Dedicated Webpage

Dedicated Support
IN NETRI's LAB
R&D & Screening Remote Services to provide predictive datas on toxicity, efficacy and modes of action in discovery & pre-clinical phases.
- Full-Time Equivalent Services
- Screening Services
- 3 Biological models
- 5 Biological applications
Applications :

Skin Cultures

CNS Cultures

PNS Cultures
TOGETHER
NETRI focus on building the microfluidic architecture and model best suited to your research needs. Understanding your needs, and translating them into the most relevant and reproducible microfluidic devices and/or models for you.
- Co-development of new models
- Designing co-culture in existing neurofluidics devices
- Adapted Protocols & Videos
- Pre-clinical to clinical partnerships

Multidisciplinary
Team

Adapted Protocols

Dedicated Webpage

Dedicated Support
Want to know more?

Anticipate the effectiveness of innovative treatments

Accelerate preclinical research phases

Reposition compounds for new indications, while limiting animal testing
APPLICATIONS

Oncology

Neuro-inflammation

Neurological Disorders

PNS Disorders

Neuro-cosmetics
Approuved by expert in the field.
Related Contents
The FAQ Page Widget is provided by the SEO Rich Snippets App.
It can be used to enter a series of frequently asked questions with their answers.
The App detects these widgets and creates structured data that can generate rich snippets in Google. Google requires at least 2 questions for this feature.
The FAQ Page Widget is provided by the SEO Rich Snippets App.
It can be used to enter a series of frequently asked questions with their answers.
The App detects these widgets and creates structured data that can generate rich snippets in Google. Google requires at least 2 questions for this feature.
High Throughput
NETRI's compartmentalized and pump-free devices, compatible with your existing lab equipment. These features allow for efficient, scalable compound testing, generating large volumes of data quickly and integrating seamlessly with standard lab setups.
Neurons as sensors
NETRI uses neurons as bio-digital sensors to create digital signatures that reflect a compound's toxicity or efficacy. This innovative method provides detailed, accurate data on how compounds affect innervated target organs, enhancing predictive accuracy in drug testing.
Digital Library
NETRI's digital library compares the digital signatures of new compounds with those of existing ones, including failed clinical trials. This comparison predicts toxicity and efficacy, leveraging historical data to improve decision-making and reduce drug development costs.
Ready to see it in action?
We like to innovate as much as you do,
get a call with an expert to benefit from NETRI Services.